 | Transgène S.A. Head office & Laboratory 11, rue de Molsheim 67082 Strasbourg Cedex France Tel.: +33 (0)3 88 27 91 00 Email: communication@transgene.fr Website: http://www.transgene.fr/ |
Transgene is a biopharmaceutical company dedicated to the discovery and development of gene-based therapeutic vaccines and immunotherapy products for the treatment of cancer and infectious diseases.
Transgene's business strategy is to develop therapeutic vaccines against cancer and infectious diseases based on its broad technology platform for gene delivery. Transgene implements this strategy in three different ways:
- by developing vaccines and products in specific indications and partnering with pharmaceutical companies for later stage development;
- by independently developing and commercializing vaccines and products for certain special markets;
- by licensing vector technologies to companies with proprietary genes for short and medium term revenues.
Source: Transgène
